Life Stages

Extend a horse’s mobility span.1

Through every life stage of horses, different management strategies may be needed to maintain their soundness. As horses are living longer, veterinarians and owners are focusing their attention on helping maintain quality of life.2 Since mobility is a vital component to quality of life for every horse, detecting problems early and administering prompt treatment when disease or injury occurs is key to maximizing and maintaining healthy joints over the horse’s life span or career. Put another way, a proactive approach to diagnosis and treatment can help extend a horse’s mobility span.

Life Stages Horse Trainer

Degenerative joint disease can affect all horses.

Whether the horse is a two-year old in training, a mature weekend warrior or a geriatric companion, proactive collaboration at all life stages between veterinarians, owners, and trainers in identifying and managing degenerative joint disease (DJD) is pivotal to healthy longevity. When you start with and stay with Adequan® I.M., horses may enjoy greater mobility over a lifetime. 3,4,5

Life Stages Horse Grass

Discover if Adequan® I.M. is the right choice for your horse.

INDICATIONS

Adequan® I.M. is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses.

How Adequan® I.M. can help extend a horse’s mobility span

Adequan Equine lifestages mobility considerations

Discover if Adequan® I.M. is the right choice for your horse.
Adequan® I.M. Polysulfated Glycosaminoglycan Sterile Injection 100 mg/mL
INDICATIONS
Adequan® I.M. is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses.
IMPORTANT SAFETY INFORMATION
Adequan® I.M. is for veterinary use only. The prescribing information contains complete use information which includes dosing, contraindications, warnings and cautions. Always read, understand and follow label and use directions. PLEASE CONSULT the Full Prescribing Information.
1. McFarlane D. "How to Establish a HealthCare Program for the Aging Horse in Equine Practice," AAEP Proceedings, 62: 2016.
2. USDA. Equine 2015: “Changes in the U.S. Equine Industry, 1998–2015” USDA–APHIS–VS–CEAH–NAHMS. Fort Collins, CO #723.0517.
3. Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY. Articular chondrocyte apoptosis in equine osteoarthritis. The Veterinary Journal 2003; 166: 52-57.
4. McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48.
5. Adequan® I.M. (polysulfated glycosaminoglycan sterile injection 100 mg/mL), Package Insert IN99501C. American Regent, Inc.
CONTACT INFORMATION
Contact Us Adverse Event Reporting Product Quality Complaints
MORE ABOUT ADEQUAN
Dosing & Administration Prescribing Information Ordering Information
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands
Animal Health Logo
All trademarks are the property of American Regent, Inc.
© 2023, American Regent, Inc.
PP-AI-CA-0004 (v2.0)